Dr. Mukesh Patekar Medical & Hemato-Oncology Specialist
Doctor Overview
- Full Name & Designation: Dr. Mukesh Patekar – Unit Head, Medical Oncology
- Specialization(s): Medical Oncology, Hemato-oncology, Pediatric Oncology, Stem Cell Transplantation, Precision Therapy, Pain & Palliative Medicine
- Years of Experience: 15+ years in medical and hemato-oncology
- Current Hospital/Institution Affiliation: Artemis Hospitals, Gurugram
Education & Training
- MBBS – Govt. Medical College, Kolhapur (MUHS Nashik)
- MD (Internal Medicine) – All India Institute of Medical Sciences (AIIMS), New Delhi
- DM (Medical Oncology) – All India Institute of Medical Sciences (AIIMS), New Delhi
Memberships
- American Society of Clinical Oncology (ASCO)
- European Society of Medical Oncology (ESMO)
- Indian Society for Medical and Pediatric Oncology (ISMPO)
Areas of Expertise
- Solid Tumors: Breast Cancer, Lung Cancer, Gastrointestinal and Hepatopancreaticobiliary Malignancies, Gynaecological & Genitourinary Malignancies, Neuro-oncology, Sarcomas
- Hematologic Malignancies: Leukemia, Lymphoma, Multiple Myeloma
- Special Interests: Pediatric Oncology, Stem Cell Transplantation (BMT), Cancer Immunotherapy, Targeted Therapy, Precision Oncology, Pain and Palliative Care
Procedures & Treatments
- Chemotherapy, Targeted Therapy, Immunotherapy
- Bone Marrow Aspiration & Biopsy
- PICC Line / Hickman / Central Line Insertion
- Lumbar Puncture / Intrathecal Chemotherapy
- Intraarterial Chemotherapy (IAC) for Retinoblastoma
- Pleurodesis
- Stem Cell Transplantation (BMT)
Awards & Achievements
- Winner – ABSICON-2018 Quiz
- 2nd Prize – National Medical Quiz
- 3rd Prize – Best Thesis Competition – ICON, Kochi
- Distinction – MBBS
Research & Publications
- Key Publications:
- Primary CNS Lymphoma in India: 17-Year Experience – Journal of Global Oncology (2019)
- Adult Burkitt Lymphoma: Institutional Experience – South Asian J Cancer (2018)
- Short Stature in Retinoblastoma – Clin Transl Oncol (2016)
- Quality of Life in Retinoblastoma – Pediatric & Blood Cancer (2016)
- Autologous Stem Cell Transplant in Multiple Myeloma – Natl Med J India (2016)
Practice Philosophy
Dr. Mukesh Patekar believes in patient-centric, holistic cancer care that integrates not only precision medicine but also psycho-oncology, nutritional support, and preventive oncology. He advocates for early detection and aims to enhance both survival rates and quality of life for his patients.
Testimonials:
“Dr. Patekar’s clarity and compassion gave me strength during my toughest days.” — Sunita R.
“Thanks to Dr. Patekar, I got a second chance at life.” — Amit M.
“His team guided us through every step—truly exceptional care.” — Rehana S.
“From diagnosis to recovery, I always felt in safe hands.” — Joseph D.
“Highly professional yet so humane—Dr. Patekar is a blessing.” — Kiran T.
Languages Spoken
- English, Hindi, Bengali, Marathi
International Patient Assistance
- Language Support
- Visa & Travel Assistance
- Virtual Consultations:
- Available upon request
- Ideal for second opinions and pre-treatment planning
Contact & Inquiry
For appointments, second opinions, or queries, please reach out to the Cancer Round Team.
Frequently Asked Questions (FAQs)
Q1. How do I book an appointment with Dr. Mukesh Patekar?
→ Contact the Cancer Round Team directly for appointment scheduling.
Q2. Does Dr. Patekar provide telemedicine consultations?
→ Yes, teleconsultations are available for both domestic and international patients.
Q3. What documents are required for a second opinion?
→ Please submit:
• Medical Reports
• Imaging (PET CT, MRI, Biopsy)
• Current Treatment Summary
Q4. What is Dr. Mukesh Patekar’s success rate in cancer treatment?
→ Among the top in India, recognized for evidence-based care and personalized treatment planning.
Q5. Which insurance plans are accepted for treatment?
→ Multiple Indian and international insurance providers accepted
Visuals & Media
Videos & Talks Featuring Dr. Mukesh Patekar:
• Webinar: Early Detection of Breast Cancer
• Swayam Course Educational Series
• Conference Presentations:
Highlights and expert insights from national and international oncology forums.
